Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT02709954

Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study I

Status
Active Not Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Yale University · Academic / Other
Sex
All
Age
21 Years – 55 Years
Healthy volunteers
Accepted

Summary

The overarching goal of this study is to characterize the effects of ethanol and cannabinoids on simulated driving and related cognition.

Detailed description

To study the effects of oral ethanol (a target BAC of \~0.04 g/dl; equivalent to consuming approximately 2 drinks over 1 hour) and vaporized THC (4 mg of THC dissolved in an ethanolic solution; equivalent to smoking approximately 1/4 of a marijuana cigarette, or "joint") on driving.

Conditions

Interventions

TypeNameDescription
DRUGActive inhaled delta-9-THCLow dose THC (\~4 mg), dissolved in alcohol. This dose is roughly equivalent to smoking approximately 1/4 of a marijuana cigarette, or "joint". Administered over 20 minutes via a vaporizer.
DRUGPlaceboControl: Approximately 4 drinks of orange juice or ginger ale covered by a trace amount of ethanol on the surface, each administered over approximately 10 minutes.
DRUGPlaceboControl: No active THC. Administered over 20 minutes via a vaporizer. approximately 10 minutes.
DRUGActive Oral Ethanol0.4 g/kg ethanol in orange juice or ginger ale to reach a target BrAC of approximately 0.04%. This dose is equivalent to consuming approximately 2 standard drinks over 1 hour. Approximately 4 drinks, each administered over approximately 10 minutes.

Timeline

Start date
2016-03-01
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2016-03-16
Last updated
2025-04-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02709954. Inclusion in this directory is not an endorsement.